Accelrys, Inc. ACCL, a
leading provider of scientific innovation lifecycle management software, is
solidifying its market leadership in the laboratory informatics space with the
acquisition of its long-time partner Vialis AG, a leading systems integrator
based in Liestal, Switzerland serving the pharmaceutical, biotechnology,
chemicals, and agro-science industries. Vialis' deep experience implementing
and supporting paperless laboratory solutions further strengthens Accelrys'
position in the laboratory informatics software market and expands the
company's capabilities in the downstream analytical development, quality
control, and quality assurance and manufacturing areas.
Under terms of the deal, Accelrys has purchased all of Vialis' outstanding
stock for approximately $5 million in cash. The acquisition includes potential
for additional incentive consideration of up to approximately $5 million in
cash, contingent upon meeting specified growth objectives over the next three
years.
"With demonstrated success in improving laboratory operations by integrating
core software systems critical to improving innovation – including electronic
laboratory notebooks, laboratory execution systems, and laboratory information
management systems – Vialis brings key domain and delivery expertise to
Accelrys, and we welcome them to our team," said Accelrys President and CEO
Max Carnecchia. "This acquisition is a natural complement to our two most
recent software acquisitions of Velquest and Aegis Corp., furthering our
strategy to deliver software solutions that optimize the
laboratory-to-commercialization value chain."
In addition to its systems integration services, Vialis' business process
consultancy delivers process improvements in lab data management. Employing a
proprietary approach to analyzing existing lab processes, Vialis' business
process consultancy services help customers optimize efficiency, enhance
quality by design efforts, increase compliance, maximize knowledge re- use and
reduce cycle times.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in